James Neal - 23 Dec 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
23 Dec 2024
Transactions value $
$1,000
Form type
4
Filing time
26 Dec 2024, 16:30:06 UTC
Previous filing
22 Nov 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $1K +2M +9% $0.00 24.2M 23 Dec 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On December 23, 2024, the Reporting Person acquired 2,000,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.